RegulatoryAlerts Logo
RegulatoryAlerts
InsightsBlogPricingSign InStart Free Trial
All EMA (EU) updates
EMA (EU)
GUIDANCE FINAL
Draft reflection paper on the investigation of drug interactions of herbal medicinal products
Published: 10/15/2026Detected: 10/15/2026

Summary preview

Provides HMPC-specific recommendations for investigating, assessing, and reporting drug–drug interaction (DDI) potential of complex herbal medicinal products (including traditional herbal medicinal products), in the…

Get the full analysis, free

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

Create free account
manufacturing
quality
clinical
safety
labeling
#herbal medicinal products
#traditional herbal medicinal products
#drug-drug interactions
#pharmacokinetic interactions
#ICH M12

Official Source Document
Source Verified

Access the original document directly from EMA.

View Official Document

More from EMA (EU)

  • European platform for regulatory science research meeting: October 202610/22/2026
  • PMS Q&A Clinic on Product User Interface (PUI) and Application Programming Interface (API) – October 202610/22/2026
  • Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - October 202610/21/2026
  • 21st industry stakeholder platform - operation of European Union (EU) pharmacovigilance10/20/2026
  • European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties meeting with all eligible organisations10/20/2026

Get EMA (EU) alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts Logo
RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

  • Insights
  • Updates by Therapeutic Area
  • FDA Updates
  • EMA Updates
  • Pricing
  • Features
  • Request Demo

Resources

  • Integration Guides
  • Regulatory Glossary
  • EMA Timeline
  • Best Practices
  • Therapeutic Areas

Company

  • About Us
  • Blog
  • Contact
  • Security
  • Privacy Policy
  • Terms of Service

    • © 2026 RegulatoryAlerts. All rights reserved.

    Not affiliated with the FDA, EMA, or Health Canada.